Skip to main content
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 16
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Spriggens, Lauren and Hides, Leanne 2015. Patterns of cannabis use, psychotic-like experiences and personality styles in young cannabis users. Schizophrenia Research, Vol. 165, Issue. 1, p. 3.

    Testa, Maria and Brown, Whitney C 2015. Does marijuana use contribute to intimate partner aggression? A brief review and directions for future research. Current Opinion in Psychology, Vol. 5, p. 6.

    Frances, R.J. 2011. Acute cannabis use causes increased psychotomimetic experiences in individuals prone to psychosis. Yearbook of Psychiatry and Applied Mental Health, Vol. 2011, p. 114.

    Christensen, Jasen 2010. A 25-Year-Old Man with a History of Schizophrenia. Psychiatric Annals, Vol. 40, Issue. 3, p. 132.

    Rohleder, Cathrin and Leweke, F. Markus 2015. Cannabinoids in Neurologic and Mental Disease.

    Richardson, T.H. 2010. Cannabis Use and Mental Health: A Review of Recent Epidemiological Research. International Journal of Pharmacology, Vol. 6, Issue. 6, p. 796.

    De Simoni, S. Schwarz, A.J. O'Daly, O.G. Marquand, A.F. Brittain, C. Gonzales, C. Stephenson, S. Williams, S.C.R. and Mehta, M.A. 2013. Test–retest reliability of the BOLD pharmacological MRI response to ketamine in healthy volunteers. NeuroImage, Vol. 64, p. 75.

    Aguilar, D. D. Chen, L. and Lodge, D. J. 2015. Increasing Endocannabinoid Levels in the Ventral Pallidum Restore Aberrant Dopamine Neuron Activity in the Subchronic PCP Rodent Model of Schizophrenia. International Journal of Neuropsychopharmacology, Vol. 18, Issue. 1, p. pyu035.

    Moreno, Margarita Estevez, Angeles F. Zaldivar, Flor Montes, Jose Manuel García Gutiérrez-Ferre, Valeria E. Esteban, Laura Sánchez-Santed, Fernando and Flores, Pilar 2012. Impulsivity differences in recreational cannabis users and binge drinkers in a university population. Drug and Alcohol Dependence, Vol. 124, Issue. 3, p. 355.

    Hindocha, Chandni Freeman, Tom P. Schafer, Grainne Gardener, Chelsea Das, Ravi K. Morgan, Celia J.A. and Curran, H. Valerie 2015. Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: A randomised, double-blind, placebo-controlled study in cannabis users. European Neuropsychopharmacology, Vol. 25, Issue. 3, p. 325.

    Szoke, Andrei Galliot, Anne-Marie Richard, Jean-Romain Ferchiou, Aziz Baudin, Grégoire Leboyer, Marion and Schürhoff, Franck 2014. Association between cannabis use and schizotypal dimensions – A meta-analysis of cross-sectional studies. Psychiatry Research, Vol. 219, Issue. 1, p. 58.

    Morgan, C. J. A. Schafer, G. Freeman, T. P. and Curran, H. V. 2010. Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study. The British Journal of Psychiatry, Vol. 197, Issue. 4, p. 285.

    Schafer, Gráinne Feilding, Amanda Morgan, Celia J.A. Agathangelou, Maria Freeman, Tom P. and Valerie Curran, H. 2012. Investigating the interaction between schizotypy, divergent thinking and cannabis use. Consciousness and Cognition, Vol. 21, Issue. 1, p. 292.

    Mason, Oliver J. and Brady, Francesca 2009. The Psychotomimetic Effects of Short-Term Sensory Deprivation. The Journal of Nervous and Mental Disease, Vol. 197, Issue. 10, p. 783.

    Hanna, Rebecca C. Perez, Jessica M. and Ghose, Subroto 2016. Cannabis and development of dual diagnoses: A literature review. The American Journal of Drug and Alcohol Abuse, p. 1.

    Carhart-Harris, R. L. Kaelen, M. Bolstridge, M. Williams, T. M. Williams, L. T. Underwood, R. Feilding, A. and Nutt, D. J. 2016. The paradoxical psychological effects of lysergic acid diethylamide (LSD). Psychological Medicine, Vol. 46, Issue. 07, p. 1379.


Acute cannabis use causes increased psychotomimetic experiences in individuals prone to psychosis

  • O. Mason (a1), C. J. A. Morgan (a1), S. K. Dhiman (a1), A. Patel (a1), N. Parti (a1), A. Patel (a1) and H. V. Curran (a1)
  • DOI:
  • Published online: 19 November 2008

Epidemiological evidence suggests a link between cannabis use and psychosis. A variety of factors have been proposed to mediate an individual's vulnerability to the harmful effects of the drug, one of which is their psychosis proneness. We hypothesized that highly psychosis-prone individuals would report more marked psychotic experiences under the acute influence of cannabis.


A group of cannabis users (n=140) completed the Psychotomimetic States Inventory (PSI) once while acutely intoxicated and again when free of cannabis. A control group (n=144) completed the PSI on two parallel test days. All participants also completed a drug history and the Schizotypal Personality Questionnaire (SPQ). Highly psychosis-prone individuals from both groups were then compared with individuals scoring low on psychosis proneness by taking those in each group scoring above and below the upper and lower quartiles using norms for the SPQ.


Smoking cannabis in a naturalistic setting reliably induced marked increases in psychotomimetic symptoms. Consistent with predictions, highly psychosis-prone individuals experienced enhanced psychotomimetic states following acute cannabis use.


These findings suggest that an individual's response to acute cannabis and their psychosis-proneness scores are related and both may be markers of vulnerability to the harmful effects of this drug.

Corresponding author
*Address for correspondence: Professor H. V. Curran, Clinical Psychopharmacology Unit, Clinical Health Psychology, University College London, Gower Street, London WC1E 6BT, UK. (Email:
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

E Barkus , J Stirling , R Hopkins , S Lewis (2006). Cannabis-induced psychosis-like experiences are associated with high schizotypy. Psychopathology 39, 139178.

DC D'Souza , E Perry , L MacDougall , Y Ammerman , T Cooper , YT Wu , G Braley , R Gueorguieve , JH Krystal (2004). The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for research. Neuropsychopharmacology 29, 15581572.

M Di Forti , PD Morrison , A Butt , RM Murray (2007). Cannabis use and psychiatric and cognitive disorders: the chicken or the egg? Current Opinion in Psychiatry 20, 228234.

B Favrat , A Ménétrey , M Augsburger , LE Rothuizen , M Appenseller , T Buclin , M Pin , P Mangin , C Giroud (2005). Two cases of ‘cannabis acute psychosis’ following the administration of oral cannabis. BMC Psychiatry 5, 1719.

DM Fergusson , LJ Horwood , EM Ridder (2005). Tests of causal linkages between cannabis use and psychotic symptoms. Addiction 100, 354366.

C Henquet , L Krabbendam , J Spauwen , C Kaplan , R Lieb , HU Wittchen , J van Os (2005). Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. British Medical Journal 330, 1115.

M Hickman , P Vickerman , J Macleod , J Kirkbride , PB Jones (2007) Cannabis and schizophreia: model projections of the impact of the rise in cannabis use on historical and future trends in schizophrenia. Addiction 102, 597606.

OJ Mason , CJA Morgan , A Stefanovic , HV Curran (2008). The Psychotomimetic States Inventory (PSI): measuring psychotic-type experiences from ketamine and cannabis. Schizophrenia Research 103, 138142.

THM Moore , S Zammit , A Lingford-Hughes , TRE Barnes , PB Jones , M Burke , L Lewis (2007). Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 370, 319328.

CJA Morgan , HV Curran (2008). Effects of cannabidiol on schizophrenia-like symptoms in cannabis users. British Journal of Psychiatry 192, 306307.

CJA Morgan , S Rossell , F Pepper , J Smart , J Blackburn , B Brandner , HV Curran (2006). Semantic priming after ketamine acutely in healthy volunteers and following chronic self-administration in substance users. Biological Psychiatry 59, 265272.

A Raine (1991). The SPQ: a scale for the assessment of schizotypal personality based on DSM-III-R criteria. Schizophrenia Bulletin 17, 555564.

PD Skosnik , L Spatz-Glenn , S Park (2001). Cannabis use is associated with schizotypy and attentional disinhibition. Schizophrenia Research 48, 8392.

JH Williams , NA Wellman , JNP Rawlins (1996). Cannabis use correlates with schizotypy in healthy people. Addiction 91, 869878.

S Zammit , G Spurlock , H Williams , N Norton , N Williams , MC O'Donovan , MJ Owen (2007). Genotype effects of CHRNA7, CNR1 and COMT in schizophrenia: interactions with tobacco and cannabis use. British Journal of Psychiatry 191, 402407.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Psychological Medicine
  • ISSN: 0033-2917
  • EISSN: 1469-8978
  • URL: /core/journals/psychological-medicine
Please enter your name
Please enter a valid email address
Who would you like to send this to? *